Fazioli, F., Sironi, M., Vecchi, A., Sozzani, S., andSpreafico, F., 1987, Aspects of the experimental immunopharmacology of oxazasporines.Methods and Findings in Experimental and Clinical Pharmacology,9, 595–604.
PubMed
Google Scholar
Frei, E. III, 1985, Curative cancer chemotherapy.Cancer Research,45, 6523–6537.
PubMed
Google Scholar
Frei, E. III, 1987, Letter to the Editor. Note re: Position paper on curative cancer chemotherapy.Cancer Res., 45:6523–6537, 1985.Cancer Research,47, 3907–3908.
Google Scholar
Geran, R. I., Greenberg, N. H., MacDonald, M. N., Schumacher, A. N., andAbbott, B. J., 1966, Protocols for screening chemical agents and natural products against animal tumors and other biological systems.Cancer Chemotherapy Reports,3, 13.
Google Scholar
Giraldi, T., Perissin, L., Zorzet, S., andRapozzi, V., 1990, Antimetastatic action of triazene derivatives.Triazenes: Chemical, Biological and Clinical Aspects, edited by T. Giraldi, T. A. Connors and G. Cartei (New York: Plenum Press), pp. 45–62.
Google Scholar
Giraldi, T., Perissin, L., Zorzet, S., Piccini, P., andRapozzi, V., 1989, Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma.European Journal of Cancer and Clinical Oncology,25, 1583–1588.
Google Scholar
Giraldi, T., Sava, G., Cherubino, R., Bottiroli, G., andMazzini, G., 1984, Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating tumor cells detected by flow cytometry.Clinical and Experimental Metastasis,2, 151–159.
PubMed
Google Scholar
Giraldi, T.,Rapozzi, V.,Perissin, L., andZorzet, S., 1990, Antimetastatic action in mice of PGI2 analog Iloprost.Proceedings of the International Conference Eicosanoids and Bioactive Lipids in Cancer and Radiation Injury (Kluwer Academic), pp. 416–418.
Giraldi, T, Sava, G., Cuman, R., Nisi, C., andLassiani, L., 1981, Selectivity of the antimetastatic cytotoxic effect of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt, (±)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.Cancer Research,41, 2524–2528.
PubMed
Google Scholar
Gorelik, E., 1987, Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.Cancer Research,47, 809–815.
PubMed
Google Scholar
Gorelik, E., Bere, W. W., andHerberman, R. B., 1984, Role of NK cells in the antimetastatic effect of anticoagulant drugs.International Journal of Cancer,33, 87–94.
Google Scholar
Herman, E. H., Witiak, D. T., Hellmann, K., andWaravdekar, D. S., 1982, Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.Advances in Pharmacology and Chemotherapy, edited by S. Garattini, A. Goldin, F. Hawking and I. J. Kopin (New York: Academic Press), pp. 249–290.
Google Scholar
Hilgard, P., Pohl, J., Stekar, J., andVoegeli, R., 1985, Oxazaphosphorines as biological response modifiers—experimental and clinical perspectives.Cancer Treatment Reviews,12, 155–162.
PubMed
Google Scholar
Honn, K., Cicone, B., andSkoff, A., 1981, Prostacyclin: a potent antimetastatic agent.Science,212, 1270–1272.
PubMed
Google Scholar
Honn, K. V., Onoda, J. M., Menter, D. G., Taylor, J. D., andSloane, B. F., 1985, Prostacyclin in the control of tumor metastasis.Biological Protection with Prostaglandins, edited by M. M. Cohen (Boca Ratan: CRC Press), pp. 91–110.
Google Scholar
Justice, A., 1985, Review of the effects of stress on cancer in laboratory animals: importance of time in stress application and type of tumor.Psychological Bulletin,98, 108–138.
PubMed
Google Scholar
Labarba, R. C., 1970, Experimental and environmental factors in cancer.Psychosomatic Medicine,32, 258–276.
Google Scholar
Le Serve, A. W., andHellmann, K., 1972, Metastases and the normalization of tumor blood vessel by ICRF-159: a new type of drug action.British Medical Journal,1, 597–601.
PubMed
Google Scholar
Milton, J. D., Carpenter, C. B., andAddison, I. E., 1976, Depressed T-cell reactivity and suppressor activity of lymphoid cells from cyclophosphamide-treated mice.Cellular Immunology,24, 308–317.
PubMed
Google Scholar
Mokyr, M. B., 1987, The MOPC-315 tumor as a model for the immunomodulatory effects of cyclophosphamide.Methods and Findings in Experimental and Clinical Pharmacology,9, 579–588.
PubMed
Google Scholar
Riley, V., 1979, Cancer and stress: overview and critique.Cancer Detection and Prevention,2, 163–195.
Google Scholar
Riley, V., Fitzmaurice, M. A., andSpackman, D. H., 1981, Animal models in biobehavioral research: effects of anxiety stress on immunocompetence and neoplasia.Perspectives on Behavioral Medicine, edited by S. M. Weiss, J. A. Herd and B. H. Fox (New York: Academic Press), pp. 371–400.
Google Scholar
Riley, V., Fitzmaurice, M. A., andSpackman, D. H., 1981, Psychoneuroimmunologic factors in neoplasia: studies in animals.Psychoneuroimmunology, edited by R. Ader (New York: Academic Press), pp. 31–102.
Google Scholar
Riley, V., Fitzmaurice, M. A., andSpackman, H., 1982, Immunocompetence and neoplasia: role of anxiety stress.Biological Mediators of Behavior and Disease: neoplasia, edited by S. M. Levy (New York: Elsevier Biomedical), pp. 175–218.
Google Scholar
Sava, G., Giraldi, T., Lassiani, L., andDogani, R., 1983, Effects of isomeric aryldimethyltriazenes on Lewis lung carcinoma growth and metastasis in mice.Chemico-Biological Interactions,46, 131–136.
PubMed
Google Scholar
Sava, G., Giraldi, T., Zupi, G., andSacchi, A., 1984, Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.Invasion and Metastasis,4, 171–178.
Google Scholar
Sava, G., Perissin, L., Zorzet, S., Piccini, P., andGiraldi, T., 1989, Antimetastatic action of the prostacyclin analog Iloprost in the mouse.Clinical and Experimental Metastasis,7, 671–678.
PubMed
Google Scholar
Siegel, S., 1956,Non-parametric Statistics for the Behavioral Sciences (New York: McGraw-Hill), p. 96.
Google Scholar
Tallarida, R. J., andMurray, R. B., 1987,Manual of Pharmacologic Calculation with Computer Programs (New York: Springer).
Google Scholar
Tsubura, E., Yamashita, T., andSone, S., 1983, Inhibition of the arrest of hematogenously disseminated tumor cells.Cancer Metastasis Reviews,2, 223–237.
PubMed
Google Scholar